 | | PRD_001230 | | Name: | D-valyl-N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-L-leucinamide | | Formula: | C18 H37 Cl N4 O3 | | Definition date: | 2014-09-03 | | Last modified: | 2017-09-14 |
|
 | | PRD_001231 | | Name: | L-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | | Formula: | C25 H35 Cl N6 O3 | | Definition date: | 2014-09-03 | | Last modified: | 2017-09-14 |
|
 | | PRD_001244 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(2S,3S)-1-[(2,4-dimethylphenyl)amino]-2-hydroxy-5-methyl-1-oxohexan-3-yl}-L-leucinamide | | Formula: | C35 H52 N4 O6 | | Definition date: | 2014-08-13 | | Last modified: | 2017-09-14 |
|
 | | PRD_002101 | | Name: | N-[(6R,9S,10R,13S,15aR,22S,24aR)-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-18-(morpholin-4-ylmethyl)-5,8,12,15,21,24-hexaoxo-13-phenyl-1,2,3,5,6,7,8,9,10,13,14,15,15a,16,19,21,22,23,24,24a-icosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide | | Formula: | C50 H63 N9 O10 | | Definition date: | 2014-07-30 | | Last modified: | 2014-07-30 |
|
 | | PRD_001171 | | Name: | Serine protease inhibitor BEZ-NLE-LYS-ARG-M9P | | Formula: | C32 H57 F3 N11 O5 | | Definition date: | 2014-07-08 | | Last modified: | 2014-07-08 |
|
 | | PRD_002092 | | Name: | L-alanyl-3,5-dibromo-L-tyrosyl-L-alanine | | Formula: | C15 H19 Br2 N3 O5 | | Definition date: | 2014-07-08 | | Last modified: | 2014-07-08 |
|
 | | PRD_001161 | | Name: | N-hexanoyl-L-valyl-N~1~-[(4S,5S,6R)-5-hydroxy-2,6-dimethyloctan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C28 H54 N4 O5 | | Description: | Originated from (S)-N1-((S,Z)-2,6-dimethyl-5-oxooct-6-en-4-yl)-2-((S)-2-hexanamido-3-methylbutanamido)-N5,N5-dimethylpentanediamide that reacts with N-terminal Thr of the protein, opening double bonds of the original compound and making two covalent linkages with the amino group and side chain hydroxyl of the Thr. The PRD represents the bound form. | | Definition date: | 2014-07-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001078 | | Name: | Peptide inhibitor MPT-DPP-DAR-G-DPN-NH2 | | Formula: | C23 H38 N9 O5 S | | Definition date: | 2014-06-25 | | Last modified: | 2014-06-25 |
|
 | | PRD_001163 | | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | | Formula: | C34 H40 N10 O15 | | Definition date: | 2014-06-18 | | Last modified: | 2017-09-14 |
|
 | | PRD_001164 | | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | | Formula: | C29 H33 N9 O12 | | Definition date: | 2014-06-18 | | Last modified: | 2017-09-14 |
|
 | | PRD_001165 | | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-glutamic acid | | Formula: | C24 H26 N8 O9 | | Definition date: | 2014-06-18 | | Last modified: | 2017-09-14 |
|
 | | PRD_001237 | | Name: | Boc-Ala-Ala-Ala-Al-CHO | | Formula: | C14 H27 N3 O5 | | Definition date: | 2014-06-18 | | Last modified: | 2023-11-03 |
|
 | | PRD_001238 | | Name: | PEPSTATIN ANALOGUE ISOVALERYL-VAL-VAL-STA-O-ET | | Formula: | C25 H47 N3 O6 | | Definition date: | 2014-06-04 | | Last modified: | 2017-05-04 |
|
 | | PRD_001162 | | Name: | Salinamide A | | Formula: | C51 H69 N7 O15 | | Description: | bicyclic depsipeptide salinamide A is a potent anti-inflammatory agent found in the marine bacterium Streptomyces sp. CNB-091. The suggested biosynthesis pathway indicates the peptide core of 1 is probably derived from the hexapeptide Thr-D-Ile-Hpg-MePhe-D-aThr-Ser (Tetrahedron Letters 39 (1998) 3915-3918). | | Definition date: | 2014-05-21 | | Last modified: | 2014-05-21 |
|
 | | PRD_001215 | | Name: | Macrocyclic Inhibitor (3R,6S,9S,12E,16S)-9-(3-AMINO-3-OXO-PROPYL)-3-[(4-BENZOYLPHENYL)METHYL]-6-(CYCLOHEXYLMETHYL)-2,5,8,11,14-PENTAOXO-1,4,7,10,15-PENTAZACYCLOICOS-12-ENE-16-CARBOXAMIDE | | Formula: | C40 H48 N7 O9 | | Definition date: | 2014-05-21 | | Last modified: | 2023-11-03 |
|
 | | PRD_001181 | | Name: | GE23077 | | Formula: | C31 H49 N9 O16 | | Definition date: | 2014-05-07 | | Last modified: | 2014-05-07 |
|
 | | PRD_001216 | | Name: | Somatostatin-14 | | Formula: | C76 H108 N18 O19 S2 | | Definition date: | 2014-05-07 | | Last modified: | 2014-05-07 |
|
 | | PRD_001059 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H104 N19 O17 S2 | | Definition date: | 2014-04-30 | | Last modified: | 2014-04-30 |
|
 | | PRD_001229 | | Name: | anti-CmABCB1 peptide | | Formula: | C100 H139 N24 O26 S | | Definition date: | 2014-04-30 | | Last modified: | 2014-04-30 |
|
 | | PRD_001097 | | Name: | Trypsin inhibitor 1 | | Formula: | C67 H106 N18 O18 S2 | | Definition date: | 2014-04-23 | | Last modified: | 2014-04-23 |
|
 | | PRD_001217 | | Name: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide (Bound Form) | | Formula: | C14 H23 Cl N2 O3 S | | Definition date: | 2014-04-23 | | Last modified: | 2017-09-14 |
|
 | | PRD_000973 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H103 N18 O18 S2 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001220 | | Name: | meta-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C35 H57 N15 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001221 | | Name: | phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C33 H52 N12 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001086 | | Name: | Microviridin J | | Formula: | C80 H108 N19 O22 | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
